CAH vs PNTG: fair value comparison
Cardinal Health, Inc. and The Pennant Group, Inc. · Updated 2026-10-19
CAH currently screens as overvalued while PNTG screens as fairly valued. Within Healthcare, PNTG currently sits closer to the top of our ranking by discount to fair value.
| CAH | PNTG | |
|---|---|---|
| Verdict | Overvalued | Fairly valued |
| Last price | $237.57 | $41.87 |
| 12-month range | $161.89–$254.06 | $23.75–$42.48 |
| Rank by discount to fair value | #75 of 108 Healthcare | #71 of 108 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | High |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Fairly Valued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: CAH fair value analysis · PNTG fair value analysis